Minesh Mehta

Minesh Mehta
Born (1957-12-14)December 14, 1957
Mbarara, Uganda
Nationality USA
Fields Radiation Oncology
Neuro Oncology
Thoracic Oncology
Institutions Northwestern University
University of Wisconsin-Madison
RTOG

Professor Minesh P Mehta, MD, FASTRO, is an American radiation oncologist and physician-scientist of Indian origin, Ugandan birth, Zambian Schooling and American Training, who has continuously contributed to the field of oncology for more than two and half decades.[1][2]

Early life

Born Minesh Prafulchandra Mehta in Uganda, in 1957, to two teachers from India, excelling early at school, with the most noteworthy achievement of topping over 70,000 students in the 1969 national examination for entry into Secondary School.[2] After moving to Zambia, he completed high school, and enrolled in the pre-medical curriculum, graduating with his Bachelors in Human Biology, with the highest degree score till then, from the University of Zambia. He completed a residency at the University of Wisconsin, where he was chief resident in radiation oncology.[3]

Career

Minesh Mehta is currently deputy director and chief of radiation oncology at Miami Cancer Institute at Baptist Health South Florida. Till January 2016, he served as medical director of the Maryland Proton Treatment Center at University of Maryland School of Medicine in Baltimore launching the area’s first proton treatment center.[4] Prior to this till 2013 at Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, he was co-director of the Radiation Oncology Residency Training Program, mentoring many young physicians who have gone on to become prominent leaders in the field. He has designed and led numerous national and international clinical studies, receiving NIH and NCI grants and winning several honors, many for his research in brain and central nervous system tumors.[3][5][6][7]

In 1988, after completing his residency training at the University of Wisconsin, he joined the Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison as an Assistant Professor, eventually becoming tenured Professor and Department Chair by 1997.[3]

Among his many accomplishments were the scientific and clinical implementation of image-guided intensity modulated radiotherapy through an NIH-funded Program Project Grant, overseeing the development of robust translational programs combining radiotherapy with targeted agents integrating advanced imaging (he was the Principal Investigator for the Imaging and Radiation Sciences Program of the University of Wisconsin Cancer Center for 15 years), and providing national and international leadership in Brain Tumor Clinical Trials through his leadership of the Brain Tumor Committee of the Radiation Therapy Oncology Group ( RTOG). The RTOG Brain Tumor Committee arguably became the most comprehensive clinical trial co-operative group committee for this disease category, completing the largest ever randomized trial in Glioblastoma, incorporating patient-specific, advanced-imaging, molecular, and cognitive/quality-of-life endpoints.[3]

Additionally, through his work in the RTOG and other clinical trial mechanisms he was instrumental in setting new standards in clinical research on Brain Metastases through a series of well-conducted multicenter, international, randomized trials, incorporating both traditional and novel endpoints, resulting in the most robust neurologic and neurocognitive dataset collection and evaluation for this condition.[8]

He developed an extensive statewide network of radiotherapy centers allied to the University, in order to robustly extend the reach of clinical research through the entire state. He also mentored the development and successful completion and re-funding of a major NIH award focusing on Cancer Disparities in Underserved Populations, and this became the benchmark for successful survey, epidemiologic, interventional, and translational research in this field. He groomed several residents and faculty who went on to major leadership and research positions, and after 10 years as Chairman. In 2007 he dedicated his efforts to further his interests in Brain and Thoracic Tumor Clinical Trials interests, as well as committing significant time to resident, national, and international education.[3][9]

Medical education

He completed Medical School at the University of Zambia in 1981, receiving numerous honors, including “Best” in Medicine, Pediatrics, Obstetrics and Gynecology, and “Best Overall Graduate”. After completing his internship and a year of residency training, he enrolled in the Radiation Oncology Residency Program at the University of Wisconsin-Madison, which he completed in 1988.[3][7]

Scientific career

His scientific career in neuro- and thoracic oncology started in 1988 and was marked by a zealous focus on evidence-based medicine through clinical and translational research, including a variety of areas such as endobronchial brachytherapy, radioimmunotherapy, stereotactic radiosurgery, fractionated stereotactic radiotherapy, image-guided and intensity-modulated radiotherapy, radioprotectors, radiosensitizers, altered fractionation, combination chemoradiotherapy as well as combining targeted agents with radiotherapy.[3]

Publications

Minesh Mehta has provided leadership for over 100 clinical protocols, authored almost 100 book chapters and published more than 800 scientific papers and abstracts. He has been a sought after national and international speaker, having delivered over 600 presentations.[3][6][10][11][12]

Roles in scientific arena

Administrative positions

He has held numerous administrative positions at the University of Wisconsin-Madison, School of Medicine and Public Health, Human Oncology including Professor, Assistant Professor, Associate Professor, Director of Residency Program, Vice-Chairman and Chairman for a decade.[10] He received Eric Wolfe Professorship[13][14] in 2007 and was recognized as a fellow of ASTRO (FASTRO)in 2009.[15]

Expertise and research interests[6]

His focus is primarily in the areas of intensity modulated radiotherapy, incorporating advanced imaging in radiotherapy treatment planning, CNS malignancies, lung cancer, pediatric neoplasms, stereotactic radiosurgery, radiosensitization, combined modality therapies, altered fractionation, cost-effectiveness, and outcomes research.[7]

He has run numerous multimodality clinical trials at the national level for both adult and pediatric CNS neoplasms. Current major thrust areas include developing molecularly-targeted agents as radiosensitizers for thoracic and CNS tumors.

Together with Thomas Rockwell Mackie, Mehtaa developed a form of radiation treatment known as Tomotherapy.[2]

Advisory boards and consulting roles

Dr. Mehta has served on over two dozen national and corporate advisory boards, including associations with several innovative start-ups, both in the biotech and medical physics arenas, allowing rapid clinical testing of life-changing oncology devices and drugs,.[9][10][16][17]

Teacher

Minesh is an educator and mentor of medical students, residents and fellows worldwide and has been awarded the Teaching Award.

Awards and honors

He has consistently been named in the listings of America’s Top Doctors for Cancer,[18] Best Physicians by Madison Business Magazine, Top Docs by Madison Magazine, AMA Physicians’ Recognition Award and The Best Doctors in America. His contribution for invention of Tomotherapy, a modern radiation delivery machine was recognized by Ladies’ Home Journal Health Breakthrough Award (2007).

Areas of expertise[9]

Notable achievements

Memberships

He is a member of several renowned national and international oncological societies, including:

References

  1. 1 2 http://fsmweb.northwestern.edu/faculty/facultyProfile.cfm?xid=20412
  2. 1 2 3 "The 2nd Annual Ladies' Home Journal Health Breakthrough Awards: Minesh P. Mehta, MD, and T. Rock Mackie, PhD: Revolutionizing Radiation Treatment". Lhj.com. Archived from the original on April 2, 2012. Retrieved 2012-06-22.
  3. 1 2 3 4 5 6 7 8 http://www.reuters.com/article/fl-baptist-health-s-fla-idUSnBw216457a+100+BSW20160121
  4. ↑ "University of Maryland School of Medicine Appoints New Medical Director For Maryland Proton Treatment Center". Somvweb.som.umaryland.edu. Retrieved 2014-06-08.
  5. ↑ "University of Maryland School of Medicine Appoints New Medical Director For Maryland Proton Treatment Center". Somvweb.som.umaryland.edu. Retrieved 2014-06-08.
  6. 1 2 3 "Minesh Mehta: Chair, Brain Tumor Committee RTOG". Retrieved April 12, 2016.
  7. 1 2 3 4 "Minesh Mehta: Faculty Member in Neuro-Oncology". F1000. 2010-11-01. Retrieved 2012-06-22.
  8. ↑ "Dr. Minesh Mehta, Radiation Oncologist, on Prevention & Treatment of Brain Metastases | GRACE :: Radiation Oncology". Cancergrace.org. 2011-04-29. Retrieved 2014-06-08.
  9. 1 2 3 "Dr. Minesh Mehta MD - Professor - UNIVERSITY OF MARYLAND - GLG Council Partner". Glgresearch.com. Retrieved 2014-06-08.
  10. 1 2 3 4 "COS Expertise - A Knowledge Management System". Myprofile.cos.com. Retrieved 2012-06-22.
  11. ↑ http://fsmweb.northwestern.edu/faculty/viewpub2.cfm?xid=20412
  12. ↑ http://www.scholars.northwestern.edu/expertPubs.asp?n=Minesh+P+Mehta&u_id=1591
  13. ↑ "Welcome to Golf Fore Wolfe and a Cure". Golfforewolfe.com. 2013-06-15. Retrieved 2014-06-08.
  14. ↑ "RSNA press release: RSNA Announces Honored Lectures and Annual Oration Topics". .rsna.org. 2008-12-01. Retrieved 2014-06-08.
  15. ↑ "ASTRO announces 2009 Fellows". Eurekalert.org. 2009-07-29. Retrieved 2014-06-08.
  16. ↑
  17. ↑ http://fsmweb.northwestern.edu/faculty/disclosure_profile_display.cfm?xid=20412
  18. ↑ "Top Doctors 2008 - Madison Magazine - September 2008". Madison Magazine. Retrieved 2014-06-08.
  19. ↑ "Home - Millennium Medical Publishing". Clinicaladvances.com. Retrieved 2014-06-08.
  20. 1 2 "University of Maryland". umm.edu. Retrieved 2016-04-14.
  21. ↑ "Brain Tumor". Rtog.org. Retrieved 2014-06-08.
This article is issued from Wikipedia - version of the Sunday, April 24, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.